Slow platelet recovery after PBPC transplantation from unrelated donors

J Jansen1, S G Hanks, L P Akard

  • 1Stem Cell Lab, Indiana Blood and Marrow Transplantation and St Francis Hospital and Health Centers, Beech Grove, IN 46107, USA. jjansen@ibmtindy.com

Bone Marrow Transplantation
|November 11, 2008
PubMed

Insights

Peripheral blood progenitor cell (PBPC) grafts from matched unrelated donors (MUDs) showed delayed platelet recovery compared to matched related donors (MRDs). Transportation time and storage conditions significantly impact MUD graft quality and patient engraftment outcomes.

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Cellular Therapy

Background:

  • Graft composition differences between matched related donors (MRDs) and matched unrelated donors (MUDs) for peripheral blood progenitor cell (PBPC) transplantation are not well understood.
  • Understanding these differences is crucial for optimizing engraftment and patient outcomes.

Purpose of the Study:

  • To compare the composition of MRD and MUD PBPC grafts.
  • To evaluate the impact of graft composition on engraftment kinetics, specifically neutrophil and platelet recovery.
  • To identify factors influencing graft quality during transportation and storage.

Main Methods:

  • Single-center study analyzing 55 MRD and 33 MUD PBPC grafts.
  • Assessment of graft composition, including CD34(+) cell counts and colony-forming units (CFU-GM).
  • Monitoring of neutrophil and platelet engraftment timelines and transfusion requirements.

Main Results:

  • MUD grafts, often from younger male donors, had higher CD34(+) cell counts but similar CFU-GM and burst forming units-erythroid compared to MRD grafts.
  • Neutrophil recovery was comparable, but platelet recovery was significantly delayed in the MUD group.
  • Lower CFU-GM counts correlated with delayed platelet recovery, and prolonged transportation times were associated with slower engraftment.

Conclusions:

  • PBPC grafts from MUDs can lead to delayed platelet recovery, potentially due to graft quality issues during transportation.
  • Storage conditions, particularly at room temperature, can degrade viable CD34(+) cells and CFU-GM.
  • In vitro proliferation assays are recommended for validating and auditing MUD graft transportation processes.